292 related articles for article (PubMed ID: 17592930)
1. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
[No Abstract] [Full Text] [Related]
2. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
da Rocha FF; Correa H
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1550-1. PubMed ID: 17692447
[No Abstract] [Full Text] [Related]
3. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
Veale D; Miles S; Smallcombe N; Ghezai H; Goldacre B; Hodsoll J
BMC Psychiatry; 2014 Nov; 14():317. PubMed ID: 25432131
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case series.
Higuma H; Kanehisa M; Maruyama Y; Ishitobi Y; Tanaka Y; Tsuru J; Hanada H; Kodama K; Isogawa K; Akiyoshi J
World J Biol Psychiatry; 2012 Jan; 13(1):14-21. PubMed ID: 22256827
[TBL] [Abstract][Full Text] [Related]
5. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study.
Selvi Y; Atli A; Aydin A; Besiroglu L; Ozdemir P; Ozdemir O
Hum Psychopharmacol; 2011 Jan; 26(1):51-7. PubMed ID: 21308781
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.
Pessina E; Albert U; Bogetto F; Maina G
Int Clin Psychopharmacol; 2009 Sep; 24(5):265-9. PubMed ID: 19629012
[TBL] [Abstract][Full Text] [Related]
7. A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder.
Matsunaga H; Hayashida K; Maebayashi K; Mito H; Kiriike N
Int J Psychiatry Clin Pract; 2011 Nov; 15(4):263-9. PubMed ID: 22121999
[TBL] [Abstract][Full Text] [Related]
8. Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial).
Sayyah M; Sayyah M; Boostani H; Ghaffari SM; Hoseini A
Depress Anxiety; 2012 Oct; 29(10):850-4. PubMed ID: 22933237
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder.
Masi G; Pfanner C; Millepiedi S; Berloffa S
J Clin Psychopharmacol; 2010 Dec; 30(6):688-93. PubMed ID: 21105283
[TBL] [Abstract][Full Text] [Related]
10. Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Romeo VM; Santoro V; Settineri S; Spina E; Zoccali RA
J Clin Psychopharmacol; 2011 Apr; 31(2):174-9. PubMed ID: 21346614
[TBL] [Abstract][Full Text] [Related]
11. Low-dose aripiprazole in the treatment of SSRI-induced bruxism.
Oulis P; Dimitrakopoulos S; Konstantakopoulos G; Tsaltas E; Kollias K
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E39. PubMed ID: 23037677
[No Abstract] [Full Text] [Related]
12. Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
Sarkar R; Klein J; Krüger S
Psychopharmacology (Berl); 2008 May; 197(4):687-8. PubMed ID: 18264798
[No Abstract] [Full Text] [Related]
13. Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms.
Villari V; Frieri T; Fagiolini A
J Clin Psychopharmacol; 2011 Jun; 31(3):375-6. PubMed ID: 21532362
[No Abstract] [Full Text] [Related]
14. Effect of aripiprazole augmentation for treatment-resistant somatoform disorder: a case series.
Nagoshi Y; Tominaga T; Fukui K
J Clin Psychopharmacol; 2014 Jun; 34(3):397-8. PubMed ID: 24525655
[No Abstract] [Full Text] [Related]
15. Carbamazepine augmentation of clomipramine in the treatment of refractory obsessive-compulsive disorder.
Iwata Y; Kotani Y; Hoshino R; Takei N; Iyo M; Mori N
J Clin Psychiatry; 2000 Jul; 61(7):528-9. PubMed ID: 10937614
[No Abstract] [Full Text] [Related]
16. Aripiprazole augmentation for a patient with partial remission of panic disorder.
Harada T; Yamada K; Sakamoto K; Ishigooka J
J Clin Psychopharmacol; 2009 Jun; 29(3):301-2. PubMed ID: 19440089
[No Abstract] [Full Text] [Related]
17. Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder.
Lai CH
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1291-3. PubMed ID: 19706223
[No Abstract] [Full Text] [Related]
18. Rapid responses of high-dose combined therapy of escitalopram and aripiprazole in a case of severe obsessive compulsive disorder with delusion.
Hou YC; Lai CH
J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E44-5. PubMed ID: 24763791
[No Abstract] [Full Text] [Related]
19. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
de Oliveira MVS; de Barros PMF; de Mathis MA; Boavista R; Chacon P; Echevarria MAN; Ferrão YA; Vattimo EFQ; Lopes AC; Torres AR; Diniz JB; Fontenelle LF; Rosário MCD; Shavitt RG; Miguel EC; da Silva RMF; Costa DLDC
Braz J Psychiatry; 2023 May; 45(2):146-161. PubMed ID: 36749887
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study.
Masi G; Pfanner C; Brovedani P
J Psychiatr Res; 2013 Aug; 47(8):1007-12. PubMed ID: 23664673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
